Usana Health Sciences
USNA
Usana Health Sciences (USNA) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| DA Davidson | Maintained | Neutral | $36.00 from $38.00 | Feb 27, 2025 |
| DA Davidson | Maintained | Neutral | $38.00 from $35.00 | Jan 2, 2025 |
| DA Davidson | Maintained | Neutral | $35.00 from $38.00 | Oct 23, 2024 |
| DA Davidson | Maintained | Neutral | $38.00 from $46.00 | Jul 25, 2024 |
| DA Davidson | Maintained | Neutral | $46.00 from $48.00 | May 7, 2024 |
| DA Davidson | Maintained | Neutral | $48.00 from $53.00 | Feb 22, 2024 |
| DA Davidson | Maintained | Neutral | $53.00 from $62.00 | Oct 25, 2023 |
Frequently asked questions
What is the latest analyst rating on USNA?
On Feb 27, 2025, DA Davidson maintained Usana Health Sciences at Neutral with a price target of $36.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.